Dobek Maria
Vice President, Accounting
Dobek Maria has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 13, 2026.
On the most recent filing, Dobek Maria is listed as Vice President, Accounting at Janux Therapeutics, Inc. Inside the rolling window, Dobek Maria reported no open-market purchases and 2 open-market sales totaling $49K in JANX. The largest disclosed transaction in the window is a sale of 2,038 JANX shares on May 11, 2026, worth $29K.
Companies traded
Other insiders at JANX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$49K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Dobek Maria made?
Dobek Maria has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Dobek Maria trade?
Dobek Maria has filed SEC Form 4 disclosures for 1 company, including JANX.
When was Dobek Maria's most recent SEC Form 4 filing?
Dobek Maria's most recent SEC Form 4 filing on Tracefour is dated May 13, 2026.
What is Dobek Maria's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Dobek Maria is listed as Vice President, Accounting.
What is Dobek Maria's total buy and sell value in the current window?
Inside the rolling retention window, Dobek Maria bought $0 and sold $49K based on SEC Form 4 filings.
What was Dobek Maria's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,038 JANX shares on 2026-05-11, worth $29K, per SEC Form 4 filings.